322 related articles for article (PubMed ID: 10935020)
1. Mammary gland development and tumorigenesis in estrogen receptor knockout mice.
Bocchinfuso WP; Korach KS
J Mammary Gland Biol Neoplasia; 1997 Oct; 2(4):323-34. PubMed ID: 10935020
[TBL] [Abstract][Full Text] [Related]
2. A mouse mammary tumor virus-Wnt-1 transgene induces mammary gland hyperplasia and tumorigenesis in mice lacking estrogen receptor-alpha.
Bocchinfuso WP; Hively WP; Couse JF; Varmus HE; Korach KS
Cancer Res; 1999 Apr; 59(8):1869-76. PubMed ID: 10213494
[TBL] [Abstract][Full Text] [Related]
3. Catechol estrogen metabolites and conjugates in mammary tumors and hyperplastic tissue from estrogen receptor-alpha knock-out (ERKO)/Wnt-1 mice: implications for initiation of mammary tumors.
Devanesan P; Santen RJ; Bocchinfuso WP; Korach KS; Rogan EG; Cavalieri E
Carcinogenesis; 2001 Sep; 22(9):1573-6. PubMed ID: 11532882
[TBL] [Abstract][Full Text] [Related]
4. Estrogen receptor null mice: what have we learned and where will they lead us?
Couse JF; Korach KS
Endocr Rev; 1999 Jun; 20(3):358-417. PubMed ID: 10368776
[TBL] [Abstract][Full Text] [Related]
5. Effect of exogenous epidermal-like growth factors on mammary gland development and differentiation in the estrogen receptor-alpha knockout (ERKO) mouse.
Kenney NJ; Bowman A; Korach KS; Barrett JC; Salomon DS
Breast Cancer Res Treat; 2003 May; 79(2):161-73. PubMed ID: 12825851
[TBL] [Abstract][Full Text] [Related]
6. Mammary gland development in adult mice requires epithelial and stromal estrogen receptor alpha.
Mueller SO; Clark JA; Myers PH; Korach KS
Endocrinology; 2002 Jun; 143(6):2357-65. PubMed ID: 12021201
[TBL] [Abstract][Full Text] [Related]
7. Estrogen receptor alpha is required for mammary development and the induction of mammary hyperplasia and epigenetic alterations in the aromatase transgenic mice.
Tekmal RR; Liu YG; Nair HB; Jones J; Perla RP; Lubahn DB; Korach KS; Kirma N
J Steroid Biochem Mol Biol; 2005 May; 95(1-5):9-15. PubMed ID: 15955696
[TBL] [Abstract][Full Text] [Related]
8. Tissue distribution and quantitative analysis of estrogen receptor-alpha (ERalpha) and estrogen receptor-beta (ERbeta) messenger ribonucleic acid in the wild-type and ERalpha-knockout mouse.
Couse JF; Lindzey J; Grandien K; Gustafsson JA; Korach KS
Endocrinology; 1997 Nov; 138(11):4613-21. PubMed ID: 9348186
[TBL] [Abstract][Full Text] [Related]
9. Introduction of estrogen receptor-alpha into the tTA/TAg conditional mouse model precipitates the development of estrogen-responsive mammary adenocarcinoma.
Tilli MT; Frech MS; Steed ME; Hruska KS; Johnson MD; Flaws JA; Furth PA
Am J Pathol; 2003 Nov; 163(5):1713-9. PubMed ID: 14578170
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of aromatase leads to hyperplasia and changes in the expression of genes involved in apoptosis, cell cycle, growth, and tumor suppressor functions in the mammary glands of transgenic mice.
Kirma N; Gill K; Mandava U; Tekmal RR
Cancer Res; 2001 Mar; 61(5):1910-8. PubMed ID: 11280746
[TBL] [Abstract][Full Text] [Related]
11. Rbpj conditional knockout reveals distinct functions of Notch4/Int3 in mammary gland development and tumorigenesis.
Raafat A; Lawson S; Bargo S; Klauzinska M; Strizzi L; Goldhar AS; Buono K; Salomon D; Vonderhaar BK; Callahan R
Oncogene; 2009 Jan; 28(2):219-30. PubMed ID: 18836481
[TBL] [Abstract][Full Text] [Related]
12. Functional mammary gland development and oncogene-induced tumor formation are not affected by the absence of the retinoblastoma gene.
Robinson GW; Wagner KU; Hennighausen L
Oncogene; 2001 Oct; 20(48):7115-9. PubMed ID: 11704837
[TBL] [Abstract][Full Text] [Related]
13. Effect of conditional knockout of the type II TGF-beta receptor gene in mammary epithelia on mammary gland development and polyomavirus middle T antigen induced tumor formation and metastasis.
Forrester E; Chytil A; Bierie B; Aakre M; Gorska AE; Sharif-Afshar AR; Muller WJ; Moses HL
Cancer Res; 2005 Mar; 65(6):2296-302. PubMed ID: 15781643
[TBL] [Abstract][Full Text] [Related]
14. Mnt-deficient mammary glands exhibit impaired involution and tumors with characteristics of myc overexpression.
Toyo-oka K; Bowen TJ; Hirotsune S; Li Z; Jain S; Ota S; Escoubet-Lozach L; Garcia-Bassets I; Lozach J; Rosenfeld MG; Glass CK; Eisenman R; Ren B; Hurlin P; Wynshaw-Boris A
Cancer Res; 2006 Jun; 66(11):5565-73. PubMed ID: 16740691
[TBL] [Abstract][Full Text] [Related]
15. Oncogenes, estradiol biotransformation, and mammary carcinogenesis.
Telang NT
Ann N Y Acad Sci; 1996 Apr; 784():277-87. PubMed ID: 8651576
[No Abstract] [Full Text] [Related]
16. Estrogen receptor knockout mice: phenotypes in the female reproductive tract.
Emmen JM; Korach KS
Gynecol Endocrinol; 2003 Apr; 17(2):169-76. PubMed ID: 12737678
[TBL] [Abstract][Full Text] [Related]
17. Lack of ductal development in the absence of functional estrogen receptor alpha delays mammary tumor formation induced by transgenic expression of ErbB2/neu.
Hewitt SC; Bocchinfuso WP; Zhai J; Harrell C; Koonce L; Clark J; Myers P; Korach KS
Cancer Res; 2002 May; 62(10):2798-805. PubMed ID: 12019156
[TBL] [Abstract][Full Text] [Related]
18. Keratinocyte growth factor induces mammary and prostatic hyperplasia and mammary adenocarcinoma in transgenic mice.
Kitsberg DI; Leder P
Oncogene; 1996 Dec; 13(12):2507-15. PubMed ID: 9000125
[TBL] [Abstract][Full Text] [Related]
19. Haploinsufficiency of the corepressor of estrogen receptor activity (REA) enhances estrogen receptor function in the mammary gland.
Mussi P; Liao L; Park SE; Ciana P; Maggi A; Katzenellenbogen BS; Xu J; O'Malley BW
Proc Natl Acad Sci U S A; 2006 Nov; 103(45):16716-21. PubMed ID: 17065319
[TBL] [Abstract][Full Text] [Related]
20. Induction of mammary gland development in estrogen receptor-alpha knockout mice.
Bocchinfuso WP; Lindzey JK; Hewitt SC; Clark JA; Myers PH; Cooper R; Korach KS
Endocrinology; 2000 Aug; 141(8):2982-94. PubMed ID: 10919287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
